Cargando…

Clinical Features of Central Retinal Vein Occlusion in Young Patients

Retinal vein occlusion (RVO) is the second most common retinal vascular disease. Central RVO (CRVO), in which obstruction occurs posterior to the lamina cribrosa due to various causes, manifests with extensive venous tortuosity, dilatation of blood vessels in the four quadrants, and retinal hemorrha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Tong, Zhong, Yi-Fan, Xue, Yan-Qi, Li, Si-Qi, Wang, Bing-Yu, Zhang, Gui-Qi, Hidasa, Iko, Zhang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191544/
https://www.ncbi.nlm.nih.gov/pubmed/35697973
http://dx.doi.org/10.1007/s40123-022-00534-7
_version_ 1784726037015298048
author Zhang, Xiao-Tong
Zhong, Yi-Fan
Xue, Yan-Qi
Li, Si-Qi
Wang, Bing-Yu
Zhang, Gui-Qi
Hidasa, Iko
Zhang, Han
author_facet Zhang, Xiao-Tong
Zhong, Yi-Fan
Xue, Yan-Qi
Li, Si-Qi
Wang, Bing-Yu
Zhang, Gui-Qi
Hidasa, Iko
Zhang, Han
author_sort Zhang, Xiao-Tong
collection PubMed
description Retinal vein occlusion (RVO) is the second most common retinal vascular disease. Central RVO (CRVO), in which obstruction occurs posterior to the lamina cribrosa due to various causes, manifests with extensive venous tortuosity, dilatation of blood vessels in the four quadrants, and retinal hemorrhage. The presence of macular edema decreases visual acuity in patients with CRVO, especially in elderly patients with hypertension, hyperlipidemia, and diabetes. In the last decade, treatment modalities for CRVO have improved, with anti-vascular endothelial growth factor agents being widely used as treatment. However, there are cases of refractory or recurrent macular edema. Moreover, CRVO also occurs in young patients. This article reviews previous studies and case reports and summarizes the differences in etiological factors, clinical manifestations, treatment, and prognosis between young and elderly patients. Due to the low incidence of CRVO in young patients, clinical data from these age groups are limited. Hence, further studies are warranted to explore the differences between age groups to improve individualization of treatment of young patients.
format Online
Article
Text
id pubmed-9191544
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-91915442022-06-17 Clinical Features of Central Retinal Vein Occlusion in Young Patients Zhang, Xiao-Tong Zhong, Yi-Fan Xue, Yan-Qi Li, Si-Qi Wang, Bing-Yu Zhang, Gui-Qi Hidasa, Iko Zhang, Han Ophthalmol Ther Review Retinal vein occlusion (RVO) is the second most common retinal vascular disease. Central RVO (CRVO), in which obstruction occurs posterior to the lamina cribrosa due to various causes, manifests with extensive venous tortuosity, dilatation of blood vessels in the four quadrants, and retinal hemorrhage. The presence of macular edema decreases visual acuity in patients with CRVO, especially in elderly patients with hypertension, hyperlipidemia, and diabetes. In the last decade, treatment modalities for CRVO have improved, with anti-vascular endothelial growth factor agents being widely used as treatment. However, there are cases of refractory or recurrent macular edema. Moreover, CRVO also occurs in young patients. This article reviews previous studies and case reports and summarizes the differences in etiological factors, clinical manifestations, treatment, and prognosis between young and elderly patients. Due to the low incidence of CRVO in young patients, clinical data from these age groups are limited. Hence, further studies are warranted to explore the differences between age groups to improve individualization of treatment of young patients. Springer Healthcare 2022-06-13 2022-08 /pmc/articles/PMC9191544/ /pubmed/35697973 http://dx.doi.org/10.1007/s40123-022-00534-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Zhang, Xiao-Tong
Zhong, Yi-Fan
Xue, Yan-Qi
Li, Si-Qi
Wang, Bing-Yu
Zhang, Gui-Qi
Hidasa, Iko
Zhang, Han
Clinical Features of Central Retinal Vein Occlusion in Young Patients
title Clinical Features of Central Retinal Vein Occlusion in Young Patients
title_full Clinical Features of Central Retinal Vein Occlusion in Young Patients
title_fullStr Clinical Features of Central Retinal Vein Occlusion in Young Patients
title_full_unstemmed Clinical Features of Central Retinal Vein Occlusion in Young Patients
title_short Clinical Features of Central Retinal Vein Occlusion in Young Patients
title_sort clinical features of central retinal vein occlusion in young patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191544/
https://www.ncbi.nlm.nih.gov/pubmed/35697973
http://dx.doi.org/10.1007/s40123-022-00534-7
work_keys_str_mv AT zhangxiaotong clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT zhongyifan clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT xueyanqi clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT lisiqi clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT wangbingyu clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT zhangguiqi clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT hidasaiko clinicalfeaturesofcentralretinalveinocclusioninyoungpatients
AT zhanghan clinicalfeaturesofcentralretinalveinocclusioninyoungpatients